Hunan Haili Chemical Industry(600731.SH): The trial operation of some production units at the Ningxia Haili Project was successful.
Hunan Haili (600731.SH) issued an announcement, the company's subsidiary Ningxia Haili Technology Co., Ltd. (hereinafter referred to as "...
Hunan Haili Chemical Industry (600731.SH) announced that a subsidiary, Ningxia Haili Technology Co., Ltd. (referred to as "Ningxia Haili"), has successfully conducted a one-time trial run of a portion of the equipment for the construction of "an annual production of 4,000 tons of methoxyfen and 5,000 tons of methylthiofungin series products, and a complementary 30,000 tons/year phosgene construction project." The equipment produced qualified products (the equipment operated well and met the standards). Upon the official start of production of the Ningxia project, the company's production capacity will be further increased, enhancing the company's competitiveness in the industry and creating better economic benefits for the company.
Related Articles

HKBN(01310): Tender offer deadline reached, offeror and its concerted action parties hold 78.08% of shares.

Yinbang Clad Material (300337.SZ) Shareholder Wuxi Xinbang intends to collectively reduce its shareholding by no more than 3%.

Eli Lilly (LLY.US) establishes a global weight loss drug strategy: replicating the successful model in the United States, but adopts a cautious attitude towards fast approval of new drugs.
HKBN(01310): Tender offer deadline reached, offeror and its concerted action parties hold 78.08% of shares.

Yinbang Clad Material (300337.SZ) Shareholder Wuxi Xinbang intends to collectively reduce its shareholding by no more than 3%.

Eli Lilly (LLY.US) establishes a global weight loss drug strategy: replicating the successful model in the United States, but adopts a cautious attitude towards fast approval of new drugs.
